Colgout colchicine 500 micrograms

Colgout is a prescription-only medication containing the active ingredient colchicine, primarily used for the treatment and prevention of gout flares. The brand is a well-established pharmaceutical name in the Oceanian region, particularly in Australia and New Zealand, where it is a common treatment for inflammatory conditions.

Manufacturing for Colgout is typically handled within Australia, although complex supply chains for pharmaceutical active ingredients may involve multiple international locations. The brand operates under the umbrella of Viatris, a global healthcare company formed through the merger of Mylan and Upjohn (formerly a division of Pfizer).

Viatris, the ultimate owner, is headquartered in the United States and manages a vast portfolio of generic and specialty medicines. In the Australian market, the product is often distributed through Alphapharm Pty Ltd, which is a key local subsidiary of the Viatris group.